Press release
Digital Diabetes Management Market Size with Growth Opportunities, Top Countries Data, Future Trends and Share with Revenue Forecast 2022 to 2031 | Medtronic, B. Braun Melsungen AG, Dexcom Inc., Abbott Laboratories, F. Hoffmann-La Roche
Digital Diabetes Management Market
The global digital diabetes management marketreport from Global Insight Services is the single authoritative source of intelligence on Digital Diabetes Management Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Read more about Digital Diabetes Management Market here: https://www.globalinsightservices.com/reports/digital-diabetes-management-market
Digital diabetes management (DDM) is the use of digital technologies to help people with diabetes manage their disease. This can include apps, websites, wearable devices, and other tools that help people track their blood sugar levels, monitor their diet and activity, and receive guidance and support from healthcare providers.
Key Trends
There are a few key trends in digital diabetes management technology.
One is the move away from traditional methods like finger-stick blood glucose tests and toward continuous glucose monitors (CGMs).
Another trend is the use of mobile apps to track blood sugar levels and other health data. This can help people with diabetes to better understand their condition and make better decisions about their treatment.
Finally, there is a trend toward using artificial intelligence (AI) to help manage diabetes. AI can be used to provide personalized recommendations about diet, exercise, and medication.
Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS24317/
Key Drivers
There are several key drivers of the digital diabetes management market.
One is the increasing prevalence of diabetes globally. According to the International Diabetes Federation, the number of people with diabetes is expected to reach 463 million by 2030.
Another key driver is the growing use of mobile devices and the internet. This has made it easier for people to access digital diabetes management tools and has made it more convenient for them to use these tools to track their condition and manage their care.
Finally, the increasing cost of healthcare is also driving demand for digital diabetes management solutions.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS24317/
Market Segments
By Product
• Smart Glucose Meter
• Continuous Blood Glucose Monitoring System
• Smart Insulin Pens
• Smart Insulin Pumps
• Apps
By Type
• Wearable Devices
• Handheld Devices
By End-user
• Hospitals
• Home settings
• Diagnostic Centers
By Region
• North America
• The U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Key Players
The digital diabetes management market includes players such as Medtronic, B. Braun Melsungen AG, Dexcom Inc., Abbott Laboratories, F. Hoffmann-La Roche, Insulet Corporation, Tandem Diabetes Care, Ascensia Diabetes Care Holdings AG, LifeScan Inc., Tidepool, and others.
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS24317/
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital Diabetes Management Market Size with Growth Opportunities, Top Countries Data, Future Trends and Share with Revenue Forecast 2022 to 2031 | Medtronic, B. Braun Melsungen AG, Dexcom Inc., Abbott Laboratories, F. Hoffmann-La Roche here
News-ID: 2811880 • Views: …
More Releases from Global Insight Services
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
